## Abstract Renal 11β‐hydroxysteroid dehydrogenase 2 (HSD2) catalyzes the conversion of active glucocorticoids to inert 11β‐keto compounds, thereby preventing the illicit binding of these hormones to mineralocorticoid receptors (MRs) and, thus, conferring aldosterone specificity. Absence or inhibit
Regulation of the 11β-hydroxysteroid dehydrogenase in the rat adrenal
✍ Scribed by Hiroyuki Morita; Eduardo N. Cozza; Ming-Yi Zhou; Elise P. Gomez-Sanchez; Damian G. Romero; Celso E. Gomez-Sanchez
- Publisher
- Springer
- Year
- 1997
- Tongue
- English
- Weight
- 736 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0969-711X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Biochemical conditions regulating the llfi-hydroxysteroid dehydrogenase activity in spleen homogenate of mice have been studied. The conversion of ll-hydroxy-to ll-dehydrosteroids is a reversible reaction. The ratio of these compounds at equilibrium and the reaction rates depend on the pH and on the
Renal sodium retention and potassium loss occur early, in many instances in the preascitic state of cirrhosis, an observation that cannot be fully explained by increased aldosterone concentrations. We therefore hypothesize that 11-hydroxysteroid dehydrogenase 2 (11-HSD2), which protects mineraloco